Following treatment with MSEOs, the mRNA levels of GABAARα1, GABAARγ2, and 5HT-2A in brain tissue of the three different concentrations of MSEOs treatment groups showed varying degrees of upregulation when compared to the insomnia model group. This evidence concerns the gene HTR2A and insomnia.